Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Mastaglio

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|February 25, 2022
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot StudyElisabetta Xue, Francesca Lorentino, Maria Teresa Lupo Stanghellini, et al.
Nature Communications|August 12, 2021
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemiaMichela Consonni, Claudio Garavaglia, Andrea Grilli, et al.
Frontiers in Oncology|September 27, 2021
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical TrialLorenzo Lazzari, Annalisa Ruggeri, Maria Teresa Lupo Stanghellini, et al.
Bone Marrow Transplantation|April 24, 2025
Risk stratification and impact of donor type on breakthrough invasive fungal infections in haematopoietic cell transplant with post-transplant cyclophosphamide and mould-active prophylaxisMatteo Chiurlo, Laura Galli, Francesca Farina, et al.
Microorganisms|January 23, 2024
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological MalignanciesGiovanni Mori, Sara Diotallevi, Francesca Farina, et al.
Haematologica|March 20, 2025
Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19Gregorio Maria Bergonzi, Jacques-Emmanuel Galimard, Federico Mario Aletti, et al.
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Therapeutic Advances in Infectious Disease|October 1, 2024
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipientsFrancesca Farina, Andrea Acerbis, Chiara Oltolini, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Bone Marrow Transplantation|July 19, 2023
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovirGiorgio Orofino, Elisabetta Xue, Matteo Doglio, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|February 25, 2022
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot StudyElisabetta Xue, Francesca Lorentino, Maria Teresa Lupo Stanghellini, et al.
Nature Communications|August 12, 2021
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemiaMichela Consonni, Claudio Garavaglia, Andrea Grilli, et al.
Frontiers in Oncology|September 27, 2021
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical TrialLorenzo Lazzari, Annalisa Ruggeri, Maria Teresa Lupo Stanghellini, et al.
Bone Marrow Transplantation|April 24, 2025
Risk stratification and impact of donor type on breakthrough invasive fungal infections in haematopoietic cell transplant with post-transplant cyclophosphamide and mould-active prophylaxisMatteo Chiurlo, Laura Galli, Francesca Farina, et al.
Microorganisms|January 23, 2024
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological MalignanciesGiovanni Mori, Sara Diotallevi, Francesca Farina, et al.
Haematologica|March 20, 2025
Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19Gregorio Maria Bergonzi, Jacques-Emmanuel Galimard, Federico Mario Aletti, et al.
Frontiers in Immunology|June 4, 2026
The conditional benefit of being alive and disease free at 2 years after transplant: a long term survival evaluation among 456 patients affected by acute myeloid leukemiaAlessandro Bruno, Francesca Lorentino, Matteo G Carrabba, et al.
Therapeutic Advances in Infectious Disease|October 1, 2024
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipientsFrancesca Farina, Andrea Acerbis, Chiara Oltolini, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Bone Marrow Transplantation|July 19, 2023
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovirGiorgio Orofino, Elisabetta Xue, Matteo Doglio, et al.
Pageof 5